Amiloidózis: nyitott vizsgálatok itt: Franciaország
32 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 2026. nov. 10.. Ask the study team whether a trial fits you.
No phaseToborozResearch participation
Quantitative Analysis of Myocardial Uptake of Bone Radiopharmaceuticals in Patients With Cardiac ATTR Amyloidosis
- Where
- Caen, Lille
- Age
- 18 év to 100 év
- People
- 35
- Run by
- University Hospital, Caen
See details and how to joinNCT04535349Regiszter frissítve: 2026-11-09
3. fázisToborozTrial-stage medicine
MAGNITUDE: A Phase 3 Study of NTLA-2001 in Participants With Transthyretin Amyloidosis With Cardiomyopathy (ATTR-CM)
- Where
- Creteil, Marseille, Paris Cedex 18, Rennes, Toulouse Cedex 9
- Age
- 18 év to 90 év
- People
- 1200 worldwide
- Run by
- Intellia Therapeutics
See details and how to joinNCT06128629EU 2023-507220-23-00Regiszter frissítve: 2026-11-04
No phaseToborozResearch participation
Multicenter Study for the Validation of an AI-based ECG Platform for Early Cardiac Amyloidosis Diagnosis
- Where
- Toulouse
- Age
- 18 év and over
- People
- 2200 worldwide
- Run by
- Idoven 1903 S.L.
See details and how to joinNCT06978660Regiszter frissítve: 2026-11-04
1. fázisToborozTrial-stage medicine
A Study of JNJ-79635322 in Participants With Relapsed or Refractory Multiple Myeloma or Previously Treated Amyloid Light-chain (AL) Amyloidosis
- Where
- Nantes, Pierre-Bénite, Rennes, Toulouse
- Age
- 18 év and over
- People
- 180 worldwide
- Run by
- Janssen Research & Development, LLC
See details and how to joinNCT05652335EU 2023-503679-12-00Regiszter frissítve: 2026-11-03
No phaseToborozResearch participation
Longitudinal Quantitative Neuromuscular MRI in Neuropathic Patients
- Where
- Marseille
- Age
- 18 év and over
- People
- 120
- Run by
- Assistance Publique Hopitaux De Marseille
See details and how to joinNCT06845644Regiszter frissítve: 2026-10-29
3. fázisCsak meghívásosTrial-stage medicine
A Study to Evaluate Vutrisiran in Patients With Transthyretin Amyloidosis With Cardiomyopathy
- Where
- Créteil, Marseille, Paris, Rennes, Toulouse
- Age
- 18 év and over
- People
- 700 worldwide
- Run by
- Alnylam Pharmaceuticals
See details and how to joinNCT06679946Regiszter frissítve: 2026-10-21
3. fázisToborozTrial-stage medicine
CLEOPATTRA: A Research Study to Look at the Effects of Treatment With a Medicine Called Coramitug (NNC6019-0001) in People With Heart Failure Due to Transthyretin Amyloid (ATTR) Amyloidosis
- Where
- Amiens, Bron, Chambray-lès-Tours, Créteil, Dijon, La Roche-sur-Yon, La Tronche, Marseille, Metz-Tessy, Montpellier, Nantes, Nice, Paris, Pessac, Poitiers, Rennes, Toulon, Toulouse, Villeurbanne
- Age
- 18 év and over
- People
- 1280 worldwide
- Run by
- Novo Nordisk A/S
See details and how to joinNCT07207811Regiszter frissítve: 2026-10-21
3. fázisToborozTrial-stage medicine
TRITON-CM: A Study to Evaluate Nucresiran in Patients With Transthyretin Amyloidosis With Cardiomyopathy
- Where
- Chambray Les Tours, Creteil Cedex, Dijon, Fort De France Cedex, Grenoble Cedex 9, Marseille, Montpellier Cedex 5, Paris, Paris Cedex 18, Pessac, Reims Cedex, Rennes Cedex 9, Rouen Cedex, Saint-Herblain, Strasbourg Cedex, Toulouse Cedex 9
- Age
- 18 év to 85 év
- People
- 1750 worldwide
- Run by
- Alnylam Pharmaceuticals
See details and how to joinNCT07052903EU 2024-519917-72-00Regiszter frissítve: 2026-10-20
No phaseToborozResearch participation
ConTTRibute: A Global Observational Study of Patients With Transthyretin (TTR)-Mediated Amyloidosis (ATTR Amyloidosis)
- Where
- Bordeaux, Bron, Créteil, Le Kremlin-Bicêtre, Marseille
- People
- 1500 worldwide
- Run by
- Alnylam Pharmaceuticals
See details and how to joinNCT04561518Regiszter frissítve: 2026-10-13
No phaseToborozResearch participation
Patisiran-Lipid Nanoparticle (LNP) Pregnancy Surveillance Program
- Where
- Nantes
- People
- 10 worldwide
- Run by
- Alnylam Pharmaceuticals
See details and how to joinNCT05040373Regiszter frissítve: 2026-10-08
3. fázisToborozTrial-stage medicine
TRITON-PN: A Study to Evaluate the Efficacy and Safety of Nucresiran in Patients With Hereditary Transthyretin Amyloidosis With Polyneuropathy
- Where
- Creteil Cedex, Le Kremlin Bicetre Cedex, Marseille
- Age
- 18 év to 85 év
- People
- 125 worldwide
- Run by
- Alnylam Pharmaceuticals
See details and how to joinNCT07223203EU 2025-522544-40-00Regiszter frissítve: 2026-10-08
No phaseToborozResearch participation
Impact of a Cardiac Rehabilitation Program on Patients With Cardiac Amyloidosis
- Where
- Montpellier
- Age
- 18 év and over
- People
- 40
- Run by
- University Hospital, Montpellier
See details and how to joinNCT07494942Regiszter frissítve: 2026-10-08
No phaseToborozResearch participation
Prevalence of Cardiac Thrombi in Cardiac Amyloidosis
- Where
- Dijon
- Age
- 18 év and over
- People
- 200
- Run by
- Centre Hospitalier Universitaire Dijon
See details and how to joinNCT07648303Regiszter frissítve: 2026-09-17
No phaseToborozResearch participation
Study of Acoramidis in Patients With Transthyretin Amyloid Cardiomyopathy
- Where
- Many Locations
- Age
- 18 év and over
- People
- 500
- Run by
- Bayer
See details and how to joinNCT07791160Regiszter frissítve: 2026-09-15
2. fázisToborozResearch participation
Exploratory Study Evaluating the Relevance of [68Ga]Ga-FAPI-46 for Staging and Identifying Progressing Patients With Transthyretin Cardiac Amyloidosis
- Where
- Nantes Cedex 1
- Age
- 18 év and over
- People
- 40
- Run by
- Nantes University Hospital
See details and how to joinNCT07549841EU 2025-523616-36-00Regiszter frissítve: 2026-09-14
3. fázisToborzás még nem indultTrial-stage medicine
An Open-Label Study to Evaluate the Long-Term Safety and Efficacy of ALXN2220 in Adults With Transthyretin Amyloid Cardiomyopathy
- Where
- Bron, Chambray-lès-Tours, Créteil, Marseille, Montpellier, Paris, Pessac, Poitiers, Rennes, Saint-Herblain, Toulouse
- People
- 1180 worldwide
- Run by
- Alexion Pharmaceuticals, Inc.
See details and how to joinNCT07789483EU 2026-526755-57-00Regiszter frissítve: 2026-08-28
No phaseToborozResearch participation
Analysis of the Evolution of SUVmax by Quantitative Analysis Method of Bisphosphonate Scintigraphy
- Where
- Lille
- Age
- 18 év and over
- People
- 30
- Run by
- GCS Ramsay Santé pour l'Enseignement et la Recherche
See details and how to joinNCT04849754Regiszter frissítve: 2026-08-20
3. fázisToborzás még nem indultTrial-stage medicine
To Evaluate the Long-term Safety and Tolerability of Acoramidis in Participants With Newly Diagnosed ATTR-CM (ACT-EARLY OLE)
- Where
- Bordeaux, Créteil, Fort De France Cedex, Le Kremlin Bicetre Cedex, Rennes, Toulouse Cedex 9
- Age
- 18 év and over
- People
- 250 worldwide
- Run by
- Eidos Therapeutics, a BridgeBio company
See details and how to joinNCT07116473EU 2024-513676-18-00Regiszter frissítve: 2026-08-11
3. fázisToborozTrial-stage medicine
Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant
- Where
- Bordeaux, Créteil, Fort De France Cedex, Le Kremlin Bicetre Cedex, Rennes, Toulouse Cedex 9
- Age
- 18 év to 75 év
- People
- 587 worldwide
- Run by
- Eidos Therapeutics, a BridgeBio company
See details and how to joinNCT06563895EU 2024-513547-82-00Regiszter frissítve: 2026-08-04
2/3. fázisCsak meghívásosResearch participation
Long-Term Follow-Up (LTFU) of Subjects Dosed With NTLA-2001
- Where
- Le Kremlin-Bicetre
- Age
- 18 év and over
- People
- 72 worldwide
- Run by
- Intellia Therapeutics
See details and how to joinNCT05697861EU 2023-507385-11-00Regiszter frissítve: 2026-08-03
No phaseToborzás még nem indultResearch participation
Prospective Evaluation of Subcutaneous Administration of Daratumumab by the FreedomEDGE® Infusion System
- Where
- Pierre-Bénite
- Age
- 18 év and over
- People
- 100
- Run by
- Hospices Civils de Lyon
See details and how to joinNCT07721350Regiszter frissítve: 2026-07-23
No phaseToborozResearch participation
Evaluation of Skin Tests in Biotherapy Allergies
- Where
- Angers
- Age
- 18 év and over
- People
- 70
- Run by
- University Hospital, Angers
See details and how to joinNCT06971848Regiszter frissítve: 2026-06-18
No phaseToborozResearch participation
Concordance for Transthyretin Amyloidosis Between Synovial Biopsy and Anterior Carpal Ligament Biopsy
- Where
- Montpellier
- Age
- 18 év and over
- People
- 500
- Run by
- Clinique Saint Jean, France
See details and how to joinNCT07644325Regiszter frissítve: 2026-06-12
No phaseToborozResearch participation
Prevalence and Significance of ATTR Aortic Valve Amyloidosis in Degenerative Aortic Stenosis
- Where
- Toulouse
- Age
- 18 év to 99 év
- People
- 100
- Run by
- University Hospital, Toulouse
See details and how to joinNCT04636684Regiszter frissítve: 2026-06-01
1/2. fázisToborozTrial-stage medicine
A Study to Assess Change in Disease Activity and Adverse Events (AE)s in Adult Participants With Immunoglobulin Light Chain (AL) Amyloidosis Receiving Etentamig (ABBV-383) as an Intravenous (IV) Infusion
- Where
- Limoges Cedex 1, Toulouse Cedex 9
- Age
- 18 év and over
- People
- 76 worldwide
- Run by
- AbbVie
See details and how to joinNCT06158854EU 2023-503429-20-00Regiszter frissítve: 2026-05-13
Minden vizsgálat (Amiloidózis) és a térkép
Ez az oldal nem orvosi tanács. Mielőtt egy vizsgálatot megkeresel, beszélj az orvosoddal.